Question 1

What is ROZANOLIXIZUMAB used for?

Accepted Answer

ROZANOLIXIZUMAB (brand name RYSTIGGO) is a Other indicated for See full prescribing information.

Question 2

How does ROZANOLIXIZUMAB work?

Accepted Answer

ROZANOLIXIZUMAB works through the following mechanism: 12.1 Mechanism of Action Rozanolixizumab-noli is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRn), resulting in the reduction of circulating IgG..

Question 3

What are the most common side effects of ROZANOLIXIZUMAB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ROZANOLIXIZUMAB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ROZANOLIXIZUMAB the same as RYSTIGGO?

Accepted Answer

RYSTIGGO is a brand name for ROZANOLIXIZUMAB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ROZANOLIXIZUMAB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations